Filter Results:
- Full text PDF available (138)
Publication Year
1983
2018
- This year (23)
- Last 5 years (106)
- Last 10 years (209)
Publication Type
Co-author
Journals and Conferences
Learn More
- Stacey Gabriel, Joe W. Gray, +306 authors Jane Peterson
- Nature
- 2011
A catalogue of molecular aberrations that cause ovarian cancer is critical for developing and deploying therapies that will improve patients’ lives. The Cancer Genome Atlas project has analysed… (More)
- Andrea H Bild, Guang Yao, +12 authors J. R. Nevins
- Nature
- 2006
The development of an oncogenic state is a complex process involving the accumulation of multiple independent mutations that lead to deregulation of cell signalling pathways central to the control of… (More)
- Celeste Leigh Pearce, Claire L Templeman, +42 authors Andrew Berchuck
- The Lancet. Oncology
- 2012
BACKGROUND
Endometriosis is a risk factor for epithelial ovarian cancer; however, whether this risk extends to all invasive histological subtypes or borderline tumours is not clear. We undertook an… (More)
- Rebecca Therese Marquez, Keith A. Baggerly, +13 authors Karen H. Lu
- Clinical cancer research : an official journal of…
- 2005
PURPOSE
Epithelial ovarian cancers are thought to arise from flattened epithelial cells that cover the ovarian surface or that line inclusion cysts. During malignant transformation, different… (More)
- Laura Jean Havrilesky, Clark M Whitehead, +6 authors Andrew Berchuck
- Gynecologic oncology
- 2008
OBJECTIVE
To determine the utility of novel combinations of biomarkers, using both a one-step and two-step assay format, to distinguish serum of early ovarian cancer patients from that of healthy… (More)
- Anil Potti, Holly Dressman, +14 authors J. R. Nevins
- Nature Medicine
- 2006
Using in vitro drug sensitivity data coupled with Affymetrix microarray data, we developed gene expression signatures that predict sensitivity to individual chemotherapeutic drugs. Each signature was… (More)
- Holly Dressman, Andrew Berchuck, +14 authors Johnathan M. Lancaster
- Journal of clinical oncology : official journal…
- 2007
PURPOSE
The purpose of this study was to develop an integrated genomic-based approach to personalized treatment of patients with advanced-stage ovarian cancer. We have used gene expression profiles… (More)
- Honglin Song, Susan J Ramus, +82 authors Simon A. Gayther
- Nature Genetics
- 2009
Epithelial ovarian cancer has a major heritable component, but the known susceptibility genes explain less than half the excess familial risk. We performed a genome-wide association study (GWAS) to… (More)
- Ellen L. Goode, Georgia Chenevix-Trench, +78 authors Penelope M Webb
- Nature Genetics
- 2010
Ovarian cancer accounts for more deaths than all other gynecological cancers combined. To identify common low-penetrance ovarian cancer susceptibility genes, we conducted a genome-wide association… (More)
- Patricia G. Moorman, Rachel T. Palmieri, Lucy Akushevich, Andrew Berchuck, Joellen Martha Schildkraut
- American journal of epidemiology
- 2009
Ovarian cancer is the most lethal gynecologic malignancy in both African-American and white women. Although prevalences of many ovarian cancer risk factors differ markedly between African Americans… (More)